Showing results (2001-2010 of 2,629) with videos related to

Sort By:
Pageof 263
Journal for Immunotherapy of Cancer|December 20, 2017
Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trialsRoman Groisberg, David S Hong, Amini Behrang, et al.
Nature Protocols|May 12, 2012
Measuring energy metabolism in cultured cells, including human pluripotent stem cells and differentiated cellsJin Zhang, Esther Nuebel, Dona R R Wisidagama, et al.
Scientific Reports|November 17, 2021
A phase I study of the WT2725 dosing emulsion in patients with advanced malignanciesSiqing Fu, David E Piccioni, Hongtao Liu, et al.
The Laryngoscope|October 11, 2021
Rate of Development of Venous Thromboembolism in Lateral Skull Base SurgeryBrian P Anderson, Pedrom C Sioshansi, Robert M Conway, et al.
Journal of Immunotherapy and Precision Oncology|June 6, 2022
Corticosteroid-Refractory Myositis After Dual BRAF and MEK Inhibition in a Patient with BRAF V600E-Mutant Metastatic Intrahepatic CholangiocarcinomaTimothy P DiPeri, Mehmet Demirhan, Daniel D Karp, et al.
The Journal of Surgical Research|May 8, 2020
Implementation of a Surgical Oncology Disparities Curriculum for Preclinical Medical StudentsKristen E Rhodin, Cierra S Hong, Lindsey A Olivere, et al.
Lupus|January 1, 1997
Decreased tumour necrosis factor-beta production in TNFB*2 homozygote: an important predisposing factor of lupus nephritis in KoreansS H Lee, S H Park, J K Min, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2011
A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancerDavid S Hong, Razelle Kurzrock, Yun Oh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2017
Phase I Trial of the Human Double Minute 2 Inhibitor MK-8242 in Patients With Advanced Solid TumorsAndrew J Wagner, Udai Banerji, Amit Mahipal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2012
Aberrations in the epidermal growth factor receptor gene in 958 patients with diverse advanced tumors: implications for therapyJ J Wheler, G S Falchook, A M Tsimberidou, et al.
Pageof 263